Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT03693573
What this trial is testing

Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00420888
What this trial is testing

ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Active Biotech AB 526
Testing effectiveness (Phase 2)Study completedNCT03066427
What this trial is testing

Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.

Who this might be right for
Clear Cell Renal Carcinoma
Spanish Oncology Genito-Urinary Group 23
Testing effectiveness (Phase 2)UnknownNCT02330783
What this trial is testing

Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Peking University Cancer Hospital & Institute 106
Not applicableActive Not RecruitingNCT02664883
What this trial is testing

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Who this might be right for
Healthy SubjectMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+3 more
University of Southern California 37
Not applicableStudy completedNCT06020651
What this trial is testing

Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside

Who this might be right for
Renal Cell CarcinomaBladder CancerMSI-H Cancer+1 more
Institut Mutualiste Montsouris 39
Large-scale testing (Phase 3)Study completedNCT01223027
What this trial is testing

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 564
Not applicableWithdrawnNCT01781442
What this trial is testing

A Post Marketing Surveillance As Required By Philippine Food And Drug Administration

Who this might be right for
Renal Cell Carcinoma
Pfizer
Testing effectiveness (Phase 2)Ended earlyNCT00151645
What this trial is testing

Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.

Who this might be right for
Metastatic Renal Cell Carcinoma
Rennes University Hospital 36
Large-scale testing (Phase 3)Study completedNCT00732914
What this trial is testing

Sequential Study to Treat Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sponsor GmbH 272
Testing effectiveness (Phase 2)Looking for participantsNCT07115043
What this trial is testing

Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more
AstraZeneca 120
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Early research (Phase 1)Ended earlyNCT00622479
What this trial is testing

Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.

Who this might be right for
Carcinoma, Renal Cell
Bayer 12
Early research (Phase 1)Looking for participantsNCT05759923
What this trial is testing

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

Who this might be right for
Advanced Ovarian CarcinomaAdvanced Renal Cell CarcinomaAdvanced Pancreatic Carcinoma+5 more
Molecure S.A. 40
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Early research (Phase 1)Looking for participantsNCT07195682
What this trial is testing

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 281
Testing effectiveness (Phase 2)Study completedNCT01141569
What this trial is testing

RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00004880
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Jonsson Comprehensive Cancer Center 14
Post-approval studies (Phase 4)Looking for participantsNCT06903312
What this trial is testing

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

Who this might be right for
Renal Cell CancerKidney NeoplasmImmunotherapy+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 409
Early research (Phase 1)Looking for participantsNCT06883539
What this trial is testing

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Who this might be right for
Solid Tumor Malignancies, CancerSolid CancersSolid Tumor Cancer+6 more
LaunXP Biomedical Co., Ltd. 24
Next Page